E-viri
Recenzirano
-
Shen, Yinzhong; Liu, Tingyi; Chen, Jun; Li, Xin; Liu, Li; Shen, Jiayin; Wang, Jiangrong; Zhang, Renfang; Sun, Meiyan; Wang, Zhenyan; Song, Wei; Qi, Tangkai; Tang, Yang; Meng, Xianmin; Zhang, Lijun; Ho, Dean; Ho, Chih‐Ming; Ding, Xianting; Lu, Hong‐Zhou
Advanced therapeutics, April 2020, 2020-04-00, Letnik: 3, Številka: 4Journal Article
Antiretroviral therapy (ART) serves as a mainstay in treating human immunodeficiency virus (HIV) infection. An HIV patient is traditionally administered the same ART regimen for life, even if his/her viral load has been reduced by several orders of magnitude from the initial viral load. Dose reduction in ART has been clinically explored in a trial‐and‐error manner to reduce side effects and improve ART sustainability. Using artificial intelligence (AI), we have discovered that drugs and doses inputs can be related to viral load reduction through a Parabolic Response Surface (PRS). The AI‐PRS platform can rationally guide a clinically‐actionable approach to identify optimized population‐wide and personalized dosing. In this prospective pilot clinical trial, a combination regimen of tenofovir (TDF), efavirenz (EFV) and lamivudine (3TC) is administered to ten patients. Using AI‐PRS, a 33% reduction in the long‐term TDF maintenance dose (200 mg) is identified compared to standard regimens (300 mg). This regimen keeps the HIV viral load below 40 copies/mL with no relapse during a 144‐week observation period. This study demonstrates that AI‐PRS can potentially serve as a scalable approach to optimize and sustain the long‐term management of HIV as well as a broad spectrum of other indications. Lifetime antiretroviral therapy (ART) is crucial for HIV/AIDS patients. To find a balance between the ART side effects and the risk of relapse, this prospective pilot clinical study harnesses the parabolic response surface, an artificial intelligence platform, to identify a personalized optimal ART dose. With it, all patients get viral suppression with no relapse during a 144‐week observation period.
Avtor
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.